Original language | English |
---|---|
Pages (from-to) | S34 |
Journal | European Journal of Cancer |
Volume | 174 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - Oct 2022 |
Preliminary results from FLAGSHP-1: A Phase I dose escalation study of ERAS-601, a potent SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors
M. McKean, M. Barve, D. Hong, A. Parikh, E. Rosen, J. Yang, R. Picard, J. Yi, L. Brail, D. Vecchio, T. Meniawy, T. John, J. Wang
Research output: Contribution to journal › Article › peer-review
2
Citations
(Scopus)